Accenture Gears Up For Q3 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Accenture plc (NYSE:ACN) is set to release third quarter financial results, before the opening bell on Thursday. Analysts…
Village Farms Cannabis Stock Down 23%: Are Lower Costs And Increasing Sales A Signal For Investors?
Despite a 23% decrease in stock price over the past month, Village Farms International (NASDAQ: VFF) showcases a robust financial outlook with compelling growth in sales and improvements in gross margins and SG&A efficiencies.
What Is The Trump Factor? Justice Dept’s Impact On Cannabis Rescheduling, Stocks And Investments
Equity research firm Zuanic & Associates convened a panel in mid-June featuring industry experts to dissect the ongoing cannabis rescheduling efforts in the US. They provided a comprehensive outlook on the rescheduling process, expected to conclude with the publication of the Final Rule in the Federal Register by November 2024.
Cracking The Code: Understanding Analyst Reviews For Merck & Co
Merck & Co (NYSE:MRK) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints…
Forecasting The Future: 4 Analyst Projections For AT&T
In the preceding three months, 4 analysts have released ratings for AT&T (NYSE:T), presenting a wide array of…
Unveiling 21 Analyst Insights On Boston Scientific
Providing a diverse range of perspectives from bullish to bearish, 21 analysts have published ratings on Boston Scientific…
Unveiling 5 Analyst Insights On Acuity Brands
Analysts’ ratings for Acuity Brands (NYSE:AYI) over the last quarter vary from bullish to bearish, as provided by…
The Latest Analyst Ratings For Arcellx
Ratings for Arcellx (NASDAQ:ACLX) were provided by 8 analysts in the past three months, showcasing a mix of…
AZEK Co Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
6 analysts have shared their evaluations of AZEK Co (NYSE:AZEK) during the recent three months, expressing a mix…
Analyst Scoreboard: 5 Ratings For Clene
In the preceding three months, 5 analysts have released ratings for Clene (NASDAQ:CLNN), presenting a wide array of…